Angled gantry technique reduced breast radiation exposure by ... ( (PHILADELPHIA) A novel angled gantr...)

Angled gantry technique reduced breast radiation exposure by 50 percent

Date:12/3/2008

(PHILADELPHIA) A novel angled gantry approach to coronary CT angiography reduced radiation exposure to the breast by more than 50%, according to Thomas Jefferson University researchers.

Ethan Halpern, M.D., associate professor of Radiology at Jefferson Medical College of Thomas Jefferson University in Philadelphia, presented the research at the 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America.

"Radiation dose to the breast during coronary CT is especially a concern for young women as the dose may increase the risk for breast cancer," Dr. Halpern said. "Physicians are working diligently to reduce the patient radiation dose related to coronary CT."

Dr. Halpern and colleagues retrospectively reviewed 100 consecutive coronary CT angiography images that were obtained with a 64 detector helical scanner. They evaluated sagital images to: 1) define the position of the breasts and the gantry angulation required to perform a CT examination parallel to the long axis of the heart; and 2) determine the reduction in breast exposure to radiation that might be accomplished by imaging the heart with an angled gantry acquisition.

The standard axial imaging plane for coronary CT angiography required a 6.5cm. 1.8 cm. overlap with the lower breast. The overlap with the lower breast using the angled scan was reduced in half to 3.2 cm 1.6 cm (P<0.001).

"Angled gantry is a feasible technique for coronary CT angiography that reduces radiation exposure to the breast by 50%," Dr. Halpern said. "These results warrant the development of machines that can perform this technique."

'/>"/>

Contact: Emily Shafer
emily.shafer@jefferson.edu
215-955-5291
Thomas Jefferson University
Source:Eurekalert

0

GOOD

Post Your Comments:

(Date:12/15/2009)... Mergers and acquisitions are commonplace today. As competitors ... complete a product portfolio they also must face ... ,, A new free, white paper from Howard ... Conservation Program: US Airways ," details how the ... the newly formed company to enhance its occupational ...

(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com ... report is available in its catalogue: ... Diseases Therapeutics - Market Forecasts to ... Deals Analysis ,, http://www.reportlinker.com/p0168098/The-Future-of-Cardiovascular-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... The author has released its latest ...

(Date:12/15/2009)... STAMFORD, Conn., Dec. 15 Aon ... of Aon Corporation (NYSE: AON ... the firm as senior vice president with ... of the national Pharmacy Practice. ,, ... her new role, Zeitel will work under ...

(Date:12/15/2009)... Research shows a direct correlation between effective workplace ... a culture of health improvement can result in ... new white paper from The Vitality Group, a ... an ideal setting for the delivery of health ... corporate culture of health is a critical component ...

(Date:12/15/2009)... -- Today, Coastal Healthcare Administrators officially announced ... the first time since its inception in ... will be assuming responsibilities and provider contracts ... Medical Care. ,, Operating on a ... working relationships with all network physicians, ancillary ...

[0] New White Paper Details Best Practices of an Occupational Hearing Conservation Program: US Airways [0] Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] Aon Consulting Adds Senior Vice President to National Pharmacy Practice [0] Optimizing Corporate Culture is Critical to the Success of Wellness Programs [0] Coastal Healthcare Administrators Expands Provider Network to Santa Clara County

... Group on Health and Pharmacy Outcomes Specialists collaborate to produce ... CHICAGO, Dec. 8 The Midwest Business Group on Health ... the second annual Pharmacy Benefits Academy (PBA) to be held ... A collaboration between MBGH and POS, the Academy is part ...

... , , MONDAY, Dec. 8 (HealthDay News) -- An international ... 40,000 people has identified 11 more regions that govern ... triglycerides. , "These locations point us to previously unsuspected ... Dr. Sekar Kathiresan, director of preventive cardiology at Massachusetts ...

... INDIANAPOLIS, Dec. 8 Amylin,Pharmaceuticals, Inc. (Nasdaq: ... LLY ),today announced that the U.S. Food and ... regulatory application for use of BYETTA(R) (exenatide),injection as stand-alone ... not achieving acceptable blood sugar control. It is likely ...

... earns regional designation , , ... the nation,s largest effort to recognize physicians for delivering ... BTE Incentive and Reward Program Endorsement. Aetna ... for meeting performance and recognition standards and principles for ...

... its acclaimed debut in 2007,MyHealthArchive revolutionized every aspect ... bringing the process into the digital age. Today,s,release ... allowing,subscribers to take charge of their health and ... their own centralized control and energizing their health,and ...

... a leading global manufacturer and marketer of nutritional supplements, today announced preliminary unaudited net sales results for the month of November ... by segment are as follows: , , , , ... NET SALES, ... ...

Other Medicine News:Health News:Pharmacy Benefits Academy Set for 2009 2 Health News:Pharmacy Benefits Academy Set for 2009 3 Health News:11 New Cholesterol Genes Identified 2 Health News:11 New Cholesterol Genes Identified 3 Health News:Amylin, Lilly Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission 2 Health News:Amylin, Lilly Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission 3 Health News:Amylin, Lilly Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission 4 Health News:Amylin, Lilly Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission 5 Health News:Health Plans Achieve Bridges to Excellence Physician Incentive and Reward Program Endorsement 2 Health News:Health Plans Achieve Bridges to Excellence Physician Incentive and Reward Program Endorsement 3 Health News:MyHealthArchive.com's New Features -- A Quantum Leap in Using Health Information to Promote Your Health 2 Health News:MyHealthArchive.com's New Features -- A Quantum Leap in Using Health Information to Promote Your Health 3 Health News:MyHealthArchive.com's New Features -- A Quantum Leap in Using Health Information to Promote Your Health 4 Health News:NBTY Announces Preliminary Unaudited Net Sales Results for November 2008 2 Health News:NBTY Announces Preliminary Unaudited Net Sales Results for November 2008 3 Health News:NBTY Announces Preliminary Unaudited Net Sales Results for November 2008 4

Pharmacy Benefits Academy Set for 2009 11 New Cholesterol Genes Identified Amylin, Lilly Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission Health Plans Achieve Bridges to Excellence Physician Incentive and Reward Program Endorsement MyHealthArchive.com's New Features -- A Quantum Leap in Using Health Information to Promote Your Health NBTY Announces Preliminary Unaudited Net Sales Results for November 2008

(Date:12/15/2009)... Dec. 15 ,, Reportlinker.com announces ... available in its catalogue: ,, Hepatitis ... Forecasts to 2015 ,, http://www.reportlinker.com/p0167309/Hepatitis-B-Vaccines---Pipeline-Analysis-and-Market-Forecasts-to-2015.html ... Analysis and Market Forecasts to 2015 ,, ... analysis specialist,s new report, "Hepatitis B Vaccines ...

(Date:12/15/2009)... NEW YORK, Dec. 15 ... research report is available in its ... A strategic assessment of the competitive ... highest priority management responsibilities, the task ... profitability. Timely and factual competitive intelligence ...

(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com ... report is available in its catalogue: ... Therapeutics - Market Forecasts to 2015, ... Analysis ,, http://www.reportlinker.com/p0168102/The-Future-of-HIV-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... author has released its latest research ...

[0] Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 [0] Reportlinker Adds Top Ten World's Leading Orthopedics Companies [0] Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

... to evaluate vandetanib as second-line NSCLC ... treatment in combination with docetaxel -, WILMINGTON, Del., Sept. ... show that the AstraZeneca,investigational once-daily oral anti-cancer drug vandetanib (ZACTIMA), ... advanced Non-Small Cell Lung Cancer (NSCLC). The Phase II ...

... to insulin glargine, exenatide offered added benefits of, ... used with metformin --, AMSTERDAM, Netherlands, Sept. ... and Eli Lilly and Company (NYSE: LLY ... injection,with insulin glargine on beta-cell function, glycemic control ...

Other Medicine Technology:Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) 2 Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) 3 Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) 4 One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 2 One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 3 One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 4 One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 5 One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 6 One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 7

Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function

... Management software- RLISYS provides ... Software, Support, and Training ... Optometry, Ophthalmology, and Opticianry- ... operations, allowing you to ...

... The Advia 120 ... to streamline laboratory workflow ... benefits. This analyzer offers ... diagnostic assays, meeting the ...

The K-4500 automated hematology analyzer offers fast reliable test results of 18-parameter plus 3-histograms, valuable for effective diagnosis....

The XT-1800i is a compact, high performance, automated hematology analyzer that provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test re...

Medicine Products:

RLISYS Advia 120 K-4500 XT-1800i

Angled gantry technique reduced breast radiation exposure by ...( (PHILADELPHIA) A novel angled gantr...),Health